nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Epirubicin—liver cancer	0.294	0.436	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—liver cancer	0.156	0.232	CbGbCtD
Atazanavir—CYP2C9—Sorafenib—liver cancer	0.064	0.095	CbGbCtD
Atazanavir—ABCB1—Sorafenib—liver cancer	0.0621	0.0922	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—liver cancer	0.0377	0.0559	CbGbCtD
Atazanavir—CYP3A4—Sorafenib—liver cancer	0.0372	0.0552	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—liver cancer	0.0226	0.0335	CbGbCtD
Atazanavir—Ritonavir—CYP2E1—liver cancer	0.00153	0.706	CrCbGaD
Atazanavir—Hiccups—Doxorubicin—liver cancer	0.000639	0.00255	CcSEcCtD
Atazanavir—Saquinavir—ALB—liver cancer	0.000637	0.294	CrCbGaD
Atazanavir—Anorexia—Sorafenib—liver cancer	0.000635	0.00254	CcSEcCtD
Atazanavir—Oesophagitis—Epirubicin—liver cancer	0.000631	0.00252	CcSEcCtD
Atazanavir—Rash maculo-papular—Epirubicin—liver cancer	0.000627	0.00251	CcSEcCtD
Atazanavir—Mouth ulceration—Epirubicin—liver cancer	0.000624	0.00249	CcSEcCtD
Atazanavir—Ecchymosis—Epirubicin—liver cancer	0.000624	0.00249	CcSEcCtD
Atazanavir—Colitis—Doxorubicin—liver cancer	0.000613	0.00245	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000607	0.00243	CcSEcCtD
Atazanavir—Fluid retention—Doxorubicin—liver cancer	0.000606	0.00242	CcSEcCtD
Atazanavir—Dyspnoea—Sorafenib—liver cancer	0.000594	0.00237	CcSEcCtD
Atazanavir—Dyspepsia—Sorafenib—liver cancer	0.000587	0.00234	CcSEcCtD
Atazanavir—Oesophagitis—Doxorubicin—liver cancer	0.000584	0.00233	CcSEcCtD
Atazanavir—Rash maculo-papular—Doxorubicin—liver cancer	0.00058	0.00232	CcSEcCtD
Atazanavir—Decreased appetite—Sorafenib—liver cancer	0.000579	0.00232	CcSEcCtD
Atazanavir—Mouth ulceration—Doxorubicin—liver cancer	0.000577	0.00231	CcSEcCtD
Atazanavir—Ecchymosis—Doxorubicin—liver cancer	0.000577	0.00231	CcSEcCtD
Atazanavir—Diabetes mellitus—Epirubicin—liver cancer	0.000576	0.0023	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000575	0.0023	CcSEcCtD
Atazanavir—Fatigue—Sorafenib—liver cancer	0.000574	0.0023	CcSEcCtD
Atazanavir—Photosensitivity—Epirubicin—liver cancer	0.000571	0.00228	CcSEcCtD
Atazanavir—Pain—Sorafenib—liver cancer	0.00057	0.00228	CcSEcCtD
Atazanavir—Constipation—Sorafenib—liver cancer	0.00057	0.00228	CcSEcCtD
Atazanavir—Vascular purpura—Epirubicin—liver cancer	0.00056	0.00224	CcSEcCtD
Atazanavir—Eczema—Epirubicin—liver cancer	0.000558	0.00223	CcSEcCtD
Atazanavir—Gastrointestinal pain—Sorafenib—liver cancer	0.000545	0.00218	CcSEcCtD
Atazanavir—Increased appetite—Epirubicin—liver cancer	0.000533	0.00213	CcSEcCtD
Atazanavir—Diabetes mellitus—Doxorubicin—liver cancer	0.000533	0.00213	CcSEcCtD
Atazanavir—Urticaria—Sorafenib—liver cancer	0.000529	0.00212	CcSEcCtD
Atazanavir—Photosensitivity—Doxorubicin—liver cancer	0.000528	0.00211	CcSEcCtD
Atazanavir—Abdominal pain—Sorafenib—liver cancer	0.000527	0.00211	CcSEcCtD
Atazanavir—Body temperature increased—Sorafenib—liver cancer	0.000527	0.00211	CcSEcCtD
Atazanavir—Dermatitis bullous—Epirubicin—liver cancer	0.000524	0.0021	CcSEcCtD
Atazanavir—Purpura—Epirubicin—liver cancer	0.00052	0.00208	CcSEcCtD
Atazanavir—Vascular purpura—Doxorubicin—liver cancer	0.000518	0.00207	CcSEcCtD
Atazanavir—Eczema—Doxorubicin—liver cancer	0.000516	0.00206	CcSEcCtD
Atazanavir—Hypoglycaemia—Epirubicin—liver cancer	0.000513	0.00205	CcSEcCtD
Atazanavir—Pain in extremity—Epirubicin—liver cancer	0.000501	0.002	CcSEcCtD
Atazanavir—Increased appetite—Doxorubicin—liver cancer	0.000493	0.00197	CcSEcCtD
Atazanavir—Affect lability—Epirubicin—liver cancer	0.000493	0.00197	CcSEcCtD
Atazanavir—Hypersensitivity—Sorafenib—liver cancer	0.000491	0.00196	CcSEcCtD
Atazanavir—Dermatitis bullous—Doxorubicin—liver cancer	0.000485	0.00194	CcSEcCtD
Atazanavir—Purpura—Doxorubicin—liver cancer	0.000481	0.00192	CcSEcCtD
Atazanavir—Asthenia—Sorafenib—liver cancer	0.000478	0.00191	CcSEcCtD
Atazanavir—Cardiac arrest—Epirubicin—liver cancer	0.000476	0.0019	CcSEcCtD
Atazanavir—Hypoglycaemia—Doxorubicin—liver cancer	0.000475	0.0019	CcSEcCtD
Atazanavir—Mood swings—Epirubicin—liver cancer	0.000475	0.0019	CcSEcCtD
Atazanavir—Pruritus—Sorafenib—liver cancer	0.000471	0.00188	CcSEcCtD
Atazanavir—Dehydration—Epirubicin—liver cancer	0.000466	0.00186	CcSEcCtD
Atazanavir—Pain in extremity—Doxorubicin—liver cancer	0.000464	0.00185	CcSEcCtD
Atazanavir—Dry skin—Epirubicin—liver cancer	0.000459	0.00184	CcSEcCtD
Atazanavir—Affect lability—Doxorubicin—liver cancer	0.000456	0.00182	CcSEcCtD
Atazanavir—Diarrhoea—Sorafenib—liver cancer	0.000456	0.00182	CcSEcCtD
Atazanavir—Breast disorder—Epirubicin—liver cancer	0.000453	0.00181	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000451	0.0018	CcSEcCtD
Atazanavir—Nasopharyngitis—Epirubicin—liver cancer	0.000448	0.00179	CcSEcCtD
Atazanavir—Gastritis—Epirubicin—liver cancer	0.000443	0.00177	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000442	0.00177	CcSEcCtD
Atazanavir—Muscular weakness—Epirubicin—liver cancer	0.000442	0.00177	CcSEcCtD
Atazanavir—Cardiac arrest—Doxorubicin—liver cancer	0.000441	0.00176	CcSEcCtD
Atazanavir—Dizziness—Sorafenib—liver cancer	0.000441	0.00176	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—liver cancer	0.000439	0.00176	CcSEcCtD
Atazanavir—Abdominal distension—Epirubicin—liver cancer	0.000436	0.00174	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—liver cancer	0.000431	0.00172	CcSEcCtD
Atazanavir—Eosinophilia—Epirubicin—liver cancer	0.000429	0.00171	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—liver cancer	0.000425	0.0017	CcSEcCtD
Atazanavir—Pancreatitis—Epirubicin—liver cancer	0.000425	0.0017	CcSEcCtD
Atazanavir—Vomiting—Sorafenib—liver cancer	0.000424	0.00169	CcSEcCtD
Atazanavir—Rash—Sorafenib—liver cancer	0.00042	0.00168	CcSEcCtD
Atazanavir—Dermatitis—Sorafenib—liver cancer	0.00042	0.00168	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—liver cancer	0.000419	0.00167	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000417	0.00167	CcSEcCtD
Atazanavir—Headache—Sorafenib—liver cancer	0.000417	0.00167	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—liver cancer	0.000415	0.00166	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—liver cancer	0.00041	0.00164	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000409	0.00163	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—liver cancer	0.000409	0.00163	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—liver cancer	0.000405	0.00162	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—liver cancer	0.000403	0.00161	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—liver cancer	0.0004	0.0016	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—liver cancer	0.000397	0.00159	CcSEcCtD
Atazanavir—Nausea—Sorafenib—liver cancer	0.000396	0.00158	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—liver cancer	0.000395	0.00158	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—liver cancer	0.000394	0.00158	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—liver cancer	0.000393	0.00157	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—liver cancer	0.000392	0.00157	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—liver cancer	0.000391	0.00156	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000383	0.00153	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—liver cancer	0.00038	0.00152	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—liver cancer	0.000378	0.00151	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—liver cancer	0.000376	0.0015	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—liver cancer	0.000376	0.0015	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—liver cancer	0.000375	0.0015	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—liver cancer	0.000375	0.0015	CcSEcCtD
Atazanavir—Sweating—Epirubicin—liver cancer	0.00037	0.00148	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—liver cancer	0.00037	0.00148	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—liver cancer	0.000368	0.00147	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—liver cancer	0.000366	0.00146	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—liver cancer	0.000365	0.00146	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—liver cancer	0.000365	0.00146	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—liver cancer	0.000362	0.00145	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—liver cancer	0.000361	0.00144	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000354	0.00142	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—liver cancer	0.000351	0.0014	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—liver cancer	0.00035	0.0014	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—liver cancer	0.000348	0.00139	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—liver cancer	0.000348	0.00139	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—liver cancer	0.000347	0.00139	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—liver cancer	0.000347	0.00139	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—liver cancer	0.000345	0.00138	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—liver cancer	0.000342	0.00137	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—liver cancer	0.000342	0.00137	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—liver cancer	0.000341	0.00137	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—liver cancer	0.000341	0.00136	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—liver cancer	0.000341	0.00136	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—liver cancer	0.00034	0.00136	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000338	0.00135	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—liver cancer	0.000328	0.00131	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—liver cancer	0.000324	0.00129	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—liver cancer	0.000323	0.00129	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—liver cancer	0.000322	0.00129	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—liver cancer	0.000321	0.00128	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—liver cancer	0.000319	0.00128	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—liver cancer	0.000317	0.00127	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—liver cancer	0.000316	0.00126	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—liver cancer	0.000315	0.00126	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—liver cancer	0.000314	0.00126	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—liver cancer	0.000314	0.00126	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—liver cancer	0.000313	0.00125	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—liver cancer	0.000312	0.00125	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—liver cancer	0.000306	0.00122	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—liver cancer	0.000304	0.00121	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—liver cancer	0.000303	0.00121	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—liver cancer	0.000302	0.00121	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—liver cancer	0.0003	0.0012	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—liver cancer	0.000299	0.0012	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—liver cancer	0.000298	0.00119	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—liver cancer	0.000297	0.00119	CcSEcCtD
Atazanavir—Tension—Epirubicin—liver cancer	0.000296	0.00118	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—liver cancer	0.000295	0.00118	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—liver cancer	0.000293	0.00117	CcSEcCtD
Atazanavir—Back pain—Epirubicin—liver cancer	0.000292	0.00117	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—liver cancer	0.000291	0.00116	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—liver cancer	0.00029	0.00116	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—liver cancer	0.000289	0.00116	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—liver cancer	0.000283	0.00113	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—liver cancer	0.000281	0.00112	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—liver cancer	0.00028	0.00112	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—liver cancer	0.000279	0.00112	CcSEcCtD
Atazanavir—Agitation—Epirubicin—liver cancer	0.000277	0.00111	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—liver cancer	0.000275	0.0011	CcSEcCtD
Atazanavir—Tension—Doxorubicin—liver cancer	0.000274	0.0011	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—liver cancer	0.000273	0.00109	CcSEcCtD
Atazanavir—Malaise—Epirubicin—liver cancer	0.000272	0.00109	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—liver cancer	0.000271	0.00108	CcSEcCtD
Atazanavir—Syncope—Epirubicin—liver cancer	0.000271	0.00108	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—liver cancer	0.00027	0.00108	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—liver cancer	0.000267	0.00107	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—liver cancer	0.000265	0.00106	CcSEcCtD
Atazanavir—Cough—Epirubicin—liver cancer	0.000263	0.00105	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—liver cancer	0.000261	0.00105	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—liver cancer	0.00026	0.00104	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—liver cancer	0.000259	0.00104	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—liver cancer	0.000257	0.00103	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—liver cancer	0.000257	0.00103	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—liver cancer	0.000257	0.00103	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—liver cancer	0.000257	0.00103	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—liver cancer	0.000256	0.00102	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000255	0.00102	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—liver cancer	0.000254	0.00101	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—liver cancer	0.000252	0.00101	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—liver cancer	0.000251	0.001	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—liver cancer	0.00025	0.001	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—liver cancer	0.000248	0.000993	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—liver cancer	0.000247	0.000986	CcSEcCtD
Atazanavir—Oedema—Epirubicin—liver cancer	0.000246	0.000984	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—liver cancer	0.000245	0.000981	CcSEcCtD
Atazanavir—Infection—Epirubicin—liver cancer	0.000245	0.000978	CcSEcCtD
Atazanavir—Cough—Doxorubicin—liver cancer	0.000244	0.000974	CcSEcCtD
Atazanavir—Shock—Epirubicin—liver cancer	0.000242	0.000969	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—liver cancer	0.000242	0.000967	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—liver cancer	0.000241	0.000965	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—liver cancer	0.000241	0.000964	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—liver cancer	0.000239	0.000956	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—liver cancer	0.000238	0.000952	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—liver cancer	0.000238	0.00095	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—liver cancer	0.000238	0.00095	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—liver cancer	0.000238	0.00095	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—liver cancer	0.000237	0.000947	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000236	0.000944	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—liver cancer	0.000235	0.000939	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—liver cancer	0.000235	0.000938	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—liver cancer	0.000232	0.000929	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—liver cancer	0.00023	0.000918	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—liver cancer	0.000228	0.000911	CcSEcCtD
Atazanavir—Infection—Doxorubicin—liver cancer	0.000226	0.000905	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000224	0.000897	CcSEcCtD
Atazanavir—Shock—Doxorubicin—liver cancer	0.000224	0.000896	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—liver cancer	0.000223	0.000893	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—liver cancer	0.000223	0.00089	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—liver cancer	0.000221	0.000885	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—liver cancer	0.00022	0.000881	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—liver cancer	0.00022	0.000878	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—liver cancer	0.000219	0.000875	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—liver cancer	0.000217	0.000868	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—liver cancer	0.000217	0.000867	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—liver cancer	0.000214	0.000856	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000213	0.00085	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—liver cancer	0.000212	0.000849	CcSEcCtD
Atazanavir—Constipation—Epirubicin—liver cancer	0.000211	0.000842	CcSEcCtD
Atazanavir—Pain—Epirubicin—liver cancer	0.000211	0.000842	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000208	0.00083	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—liver cancer	0.000206	0.000824	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—liver cancer	0.000203	0.000812	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—liver cancer	0.000203	0.000811	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—liver cancer	0.000203	0.00081	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—liver cancer	0.000201	0.000805	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—liver cancer	0.000201	0.000802	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—liver cancer	0.000198	0.000792	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000197	0.000786	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—liver cancer	0.000196	0.000785	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—liver cancer	0.000196	0.000782	CcSEcCtD
Atazanavir—Pain—Doxorubicin—liver cancer	0.000195	0.000779	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—liver cancer	0.000195	0.000779	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—liver cancer	0.000195	0.000778	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—liver cancer	0.000195	0.000778	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—liver cancer	0.000188	0.000751	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000186	0.000745	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—liver cancer	0.000181	0.000725	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—liver cancer	0.000181	0.000724	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—liver cancer	0.00018	0.00072	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—liver cancer	0.00018	0.00072	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—liver cancer	0.000177	0.000706	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—liver cancer	0.000174	0.000696	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—liver cancer	0.000168	0.000674	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—liver cancer	0.000168	0.000671	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—liver cancer	0.000163	0.000654	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—liver cancer	0.000163	0.000651	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—liver cancer	0.000161	0.000644	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—liver cancer	0.000157	0.000626	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—liver cancer	0.000156	0.000623	CcSEcCtD
Atazanavir—Rash—Epirubicin—liver cancer	0.000155	0.000621	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—liver cancer	0.000155	0.00062	CcSEcCtD
Atazanavir—Headache—Epirubicin—liver cancer	0.000154	0.000617	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—liver cancer	0.000151	0.000602	CcSEcCtD
Atazanavir—Nausea—Epirubicin—liver cancer	0.000146	0.000585	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—liver cancer	0.000145	0.000579	CcSEcCtD
Atazanavir—Rash—Doxorubicin—liver cancer	0.000144	0.000574	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—liver cancer	0.000144	0.000574	CcSEcCtD
Atazanavir—Headache—Doxorubicin—liver cancer	0.000143	0.000571	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—liver cancer	0.000135	0.000541	CcSEcCtD
Atazanavir—ABCC1—Metabolism—NR1H4—liver cancer	7.26e-05	0.000975	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.24e-05	0.000973	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTA3—liver cancer	7.14e-05	0.000959	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.07e-05	0.00095	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	7e-05	0.00094	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ALDOB—liver cancer	6.95e-05	0.000933	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—VEGFA—liver cancer	6.9e-05	0.000927	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—HMOX1—liver cancer	6.87e-05	0.000923	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HPGDS—liver cancer	6.86e-05	0.000922	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.82e-05	0.000917	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.78e-05	0.000911	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.68e-05	0.000898	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTA4—liver cancer	6.53e-05	0.000877	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.38e-05	0.000857	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTA2—liver cancer	6.36e-05	0.000855	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TGFB1—liver cancer	6.33e-05	0.000851	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GGT1—liver cancer	6.22e-05	0.000836	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.21e-05	0.000835	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	6.14e-05	0.000825	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTA1—liver cancer	6.14e-05	0.000825	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.13e-05	0.000824	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PSMA4—liver cancer	6.12e-05	0.000822	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PSMD10—liver cancer	6.12e-05	0.000822	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NAT2—liver cancer	6.07e-05	0.000815	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	6.02e-05	0.000809	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GOT2—liver cancer	5.95e-05	0.000799	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TNF—liver cancer	5.91e-05	0.000794	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—UGDH—liver cancer	5.91e-05	0.000794	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.83e-05	0.000784	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—ALB—liver cancer	5.83e-05	0.000784	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALDOB—liver cancer	5.82e-05	0.000782	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	5.69e-05	0.000765	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2E1—liver cancer	5.59e-05	0.000752	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.59e-05	0.000751	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—EPT1—liver cancer	5.56e-05	0.000747	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CRABP1—liver cancer	5.55e-05	0.000746	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—PPARA—liver cancer	5.55e-05	0.000745	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.54e-05	0.000744	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—UGDH—liver cancer	5.52e-05	0.000742	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.51e-05	0.000741	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ADAM17—liver cancer	5.49e-05	0.000738	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.42e-05	0.000728	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—RAF1—liver cancer	5.27e-05	0.000709	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TAT—liver cancer	5.27e-05	0.000708	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYCS—liver cancer	5.23e-05	0.000703	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EPT1—liver cancer	5.19e-05	0.000698	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PSMD10—liver cancer	5.16e-05	0.000694	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PSMA4—liver cancer	5.16e-05	0.000694	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.14e-05	0.00069	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GOT1—liver cancer	5.14e-05	0.00069	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GGT1—liver cancer	5.14e-05	0.00069	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.08e-05	0.000683	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.07e-05	0.000681	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GOT2—liver cancer	5.02e-05	0.000675	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5e-05	0.000671	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TAT—liver cancer	4.92e-05	0.000661	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.87e-05	0.000654	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HPGDS—liver cancer	4.85e-05	0.000652	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.84e-05	0.00065	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.82e-05	0.000648	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.8e-05	0.000645	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTP1—liver cancer	4.61e-05	0.00062	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMOX1—liver cancer	4.55e-05	0.000611	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.47e-05	0.0006	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.39e-05	0.00059	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.34e-05	0.000583	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GOT1—liver cancer	4.34e-05	0.000582	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PSMD10—liver cancer	4.32e-05	0.000581	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PSMA4—liver cancer	4.32e-05	0.000581	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTM1—liver cancer	4.24e-05	0.00057	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GOT2—liver cancer	4.21e-05	0.000565	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	4.12e-05	0.000554	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.09e-05	0.00055	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP1A1—liver cancer	4.02e-05	0.00054	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.01e-05	0.000539	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PRKCE—liver cancer	4e-05	0.000537	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2E1—liver cancer	3.95e-05	0.000531	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.91e-05	0.000525	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.9e-05	0.000524	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.87e-05	0.00052	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.83e-05	0.000514	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.78e-05	0.000508	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.76e-05	0.000505	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MTHFR—liver cancer	3.75e-05	0.000503	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	3.73e-05	0.000501	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYCS—liver cancer	3.7e-05	0.000497	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.69e-05	0.000495	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARA—liver cancer	3.68e-05	0.000494	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UGDH—liver cancer	3.64e-05	0.000489	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GGT1—liver cancer	3.63e-05	0.000488	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GOT1—liver cancer	3.63e-05	0.000488	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.62e-05	0.000487	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CPT1B—liver cancer	3.58e-05	0.000481	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GLUL—liver cancer	3.58e-05	0.000481	CbGpPWpGaD
Atazanavir—ABCC1—Disease—H2AFX—liver cancer	3.49e-05	0.000469	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NR1H4—liver cancer	3.45e-05	0.000464	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EPT1—liver cancer	3.42e-05	0.00046	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.4e-05	0.000457	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA3—liver cancer	3.4e-05	0.000456	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CPT1B—liver cancer	3.35e-05	0.00045	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GLUL—liver cancer	3.35e-05	0.00045	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.3e-05	0.000444	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.27e-05	0.000439	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—liver cancer	3.26e-05	0.000438	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TAT—liver cancer	3.25e-05	0.000436	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NR1H4—liver cancer	3.23e-05	0.000433	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMOX1—liver cancer	3.22e-05	0.000432	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA3—liver cancer	3.17e-05	0.000426	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTHFR—liver cancer	3.16e-05	0.000425	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TERT—liver cancer	3.15e-05	0.000424	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—liver cancer	3.15e-05	0.000423	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.13e-05	0.000421	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.13e-05	0.00042	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA4—liver cancer	3.11e-05	0.000417	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—liver cancer	3.04e-05	0.000408	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA2—liver cancer	3.03e-05	0.000407	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—liver cancer	3e-05	0.000403	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA1—liver cancer	2.92e-05	0.000392	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.92e-05	0.000392	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA4—liver cancer	2.9e-05	0.00039	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.89e-05	0.000389	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NAT2—liver cancer	2.89e-05	0.000388	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1A1—liver cancer	2.84e-05	0.000382	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.84e-05	0.000381	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA2—liver cancer	2.83e-05	0.00038	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOB—liver cancer	2.77e-05	0.000372	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—liver cancer	2.77e-05	0.000372	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—liver cancer	2.73e-05	0.000367	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA1—liver cancer	2.73e-05	0.000366	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NAT2—liver cancer	2.7e-05	0.000362	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.66e-05	0.000357	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—liver cancer	2.66e-05	0.000357	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—liver cancer	2.65e-05	0.000356	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CRABP1—liver cancer	2.64e-05	0.000355	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.64e-05	0.000355	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARA—liver cancer	2.6e-05	0.000349	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.59e-05	0.000348	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOB—liver cancer	2.59e-05	0.000347	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.57e-05	0.000346	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—liver cancer	2.5e-05	0.000336	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CRABP1—liver cancer	2.47e-05	0.000331	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—liver cancer	2.41e-05	0.000324	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—liver cancer	2.34e-05	0.000314	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.33e-05	0.000314	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—liver cancer	2.31e-05	0.00031	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HPGDS—liver cancer	2.31e-05	0.00031	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—liver cancer	2.23e-05	0.000299	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.22e-05	0.000298	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GLUL—liver cancer	2.21e-05	0.000296	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CPT1B—liver cancer	2.21e-05	0.000296	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.17e-05	0.000292	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HPGDS—liver cancer	2.16e-05	0.00029	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—liver cancer	2.15e-05	0.000289	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.14e-05	0.000288	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NR1H4—liver cancer	2.13e-05	0.000286	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA3—liver cancer	2.09e-05	0.000281	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAF1—liver cancer	2.09e-05	0.00028	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMA4—liver cancer	2.06e-05	0.000276	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMD10—liver cancer	2.06e-05	0.000276	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—liver cancer	2.04e-05	0.000274	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—liver cancer	2.04e-05	0.000274	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT2—liver cancer	2e-05	0.000269	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.96e-05	0.000264	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—liver cancer	1.96e-05	0.000263	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.95e-05	0.000262	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—liver cancer	1.93e-05	0.000259	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.93e-05	0.000259	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMA4—liver cancer	1.92e-05	0.000258	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMD10—liver cancer	1.92e-05	0.000258	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA4—liver cancer	1.91e-05	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1B—liver cancer	1.91e-05	0.000257	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2E1—liver cancer	1.88e-05	0.000253	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT2—liver cancer	1.87e-05	0.000251	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA2—liver cancer	1.86e-05	0.00025	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CTNNB1—liver cancer	1.81e-05	0.000243	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA1—liver cancer	1.8e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NAT2—liver cancer	1.78e-05	0.000239	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.77e-05	0.000238	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—liver cancer	1.76e-05	0.000237	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYCS—liver cancer	1.76e-05	0.000237	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2E1—liver cancer	1.76e-05	0.000236	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT1—liver cancer	1.73e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GGT1—liver cancer	1.73e-05	0.000232	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOB—liver cancer	1.71e-05	0.000229	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—liver cancer	1.71e-05	0.000229	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.7e-05	0.000229	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYCS—liver cancer	1.64e-05	0.000221	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CRABP1—liver cancer	1.63e-05	0.000219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT1—liver cancer	1.61e-05	0.000217	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GGT1—liver cancer	1.61e-05	0.000217	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—liver cancer	1.57e-05	0.000211	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—liver cancer	1.55e-05	0.000208	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—liver cancer	1.53e-05	0.000206	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—liver cancer	1.47e-05	0.000198	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—liver cancer	1.46e-05	0.000196	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—liver cancer	1.46e-05	0.000196	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—liver cancer	1.45e-05	0.000195	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—liver cancer	1.43e-05	0.000192	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—liver cancer	1.43e-05	0.000192	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HPGDS—liver cancer	1.42e-05	0.000191	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A1—liver cancer	1.35e-05	0.000182	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—liver cancer	1.35e-05	0.000182	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—liver cancer	1.33e-05	0.000179	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMD10—liver cancer	1.27e-05	0.00017	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMA4—liver cancer	1.27e-05	0.00017	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A1—liver cancer	1.26e-05	0.00017	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—liver cancer	1.26e-05	0.000169	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—liver cancer	1.24e-05	0.000167	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARA—liver cancer	1.24e-05	0.000166	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT2—liver cancer	1.23e-05	0.000166	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—liver cancer	1.2e-05	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—liver cancer	1.18e-05	0.000158	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2E1—liver cancer	1.16e-05	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARA—liver cancer	1.15e-05	0.000155	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HRAS—liver cancer	1.15e-05	0.000154	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—liver cancer	1.1e-05	0.000148	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYCS—liver cancer	1.08e-05	0.000146	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT1—liver cancer	1.06e-05	0.000143	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GGT1—liver cancer	1.06e-05	0.000143	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—liver cancer	1.06e-05	0.000142	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—liver cancer	1.04e-05	0.00014	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	0.000139	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—liver cancer	1.02e-05	0.000137	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—liver cancer	1.01e-05	0.000136	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—liver cancer	9.89e-06	0.000133	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—liver cancer	9.56e-06	0.000128	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—liver cancer	9.55e-06	0.000128	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—liver cancer	9.43e-06	0.000127	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—liver cancer	9.31e-06	0.000125	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—liver cancer	9.19e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—liver cancer	8.78e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—liver cancer	8.69e-06	0.000117	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—liver cancer	8.58e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—liver cancer	8.49e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A1—liver cancer	8.33e-06	0.000112	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—liver cancer	8.11e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—liver cancer	7.76e-06	0.000104	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARA—liver cancer	7.62e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—liver cancer	7.58e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—liver cancer	6.52e-06	8.76e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—liver cancer	6.3e-06	8.46e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—liver cancer	5.73e-06	7.7e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—liver cancer	5.66e-06	7.61e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—liver cancer	5e-06	6.72e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—liver cancer	4.95e-06	6.64e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—liver cancer	4.62e-06	6.21e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—liver cancer	4.04e-06	5.43e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—liver cancer	3.77e-06	5.07e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—liver cancer	3.05e-06	4.09e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—liver cancer	2.49e-06	3.34e-05	CbGpPWpGaD
